Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, accounting for approximately 15% of cases, and is defined by the lack of expression of hormone receptors (estrogen and progesterone receptors) and lack of amplification or overexpression of human epidermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jinhong, Liu, Feiqi, Song, Yanqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533235/
https://www.ncbi.nlm.nih.gov/pubmed/33061626
http://dx.doi.org/10.2147/CMAR.S272685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533235/
https://www.ncbi.nlm.nih.gov/pubmed/33061626
http://dx.doi.org/10.2147/CMAR.S272685

Ejemplares similares